Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2
A first-time look at how COVID hit every town in New Jersey
8 April 2021Inhibiting production of a key material biosynthesis to slow tumor growth
8 April 2021Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2
A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused cells in the lungs of patients with COVID-19, according to laboratory experiments reported this week in Nature.
